Award
National Institute of Allergy and Infectious Diseases RFA-AI-21-050
Center for Antiviral Medicines & Pandemic Preparedness (CAMPP)
Recipient
SCRIPPS RESEARCH INSTITUTE, THE
Award Amount
$67,624,156.00
Ceiling
$67,624,156.00
Awarded
May 16, 2022
Identifier
RFA-AI-21-050
Award for development of antiviral therapeutics targeting SARS-CoV-2 and other RNA viruses, focusing on oral bioavailability and in vivo proof-of-concept.
Description
The project aims to develop antiviral therapeutics against SARS-CoV-2 and other RNA viruses of pandemic potential, including development of inhibitors for viral proteins and structural proteins, with a focus on oral bioavailability and in vivo proof-of-concept.